First Republic Investment Management, Inc. Abb Vie Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 2,228,037 shares of ABBV stock, worth $434 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

2,228,037

Previous 2,343,391 4.92%

Holding current value

$434 Million

Previous $316 Million 5.19%

% of portfolio

0.96%

Previous 1.65%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $15.4 Million - $17.8 Million	-115,354 Reduced 4.92%	2,228,037 $332 Million
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $11.4 Million - $14.1 Million	85,705 Added 3.8%	2,343,391 $316 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $6.34 Million - $7.3 Million	43,815 Added 1.98%	2,257,686 $360 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $12.8 Million - $15.4 Million	92,549 Added 4.36%	2,213,871 $358 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $20.4 Million - $23.3 Million	-151,635 Reduced 6.67%	2,121,322 $285 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $16.6 Million - $21.2 Million	120,902 Added 5.62%	2,272,957 $348 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $25.2 Million - $31.3 Million	191,159 Added 9.75%	2,152,055 $349 Million
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $6.28 Million - $7.95 Million	58,459 Added 3.07%	1,960,896 $266 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $10.4 Million - $11.9 Million	98,204 Added 5.44%	1,902,437 $205 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $36.5 Million - $40.7 Million	347,242 Added 23.83%	1,804,233 $203 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $13.6 Million - $15 Million	-132,996 Reduced 8.36%	1,456,991 $158 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $21.2 Million - $28.7 Million	263,908 Added 19.9%	1,589,987 $170 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $8.66 Million - $10.2 Million	100,848 Added 8.23%	1,326,079 $116 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $11.6 Million - $15.5 Million	157,996 Added 14.8%	1,225,231 $120 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $5.6 Million - $8.48 Million	86,748 Added 8.85%	1,067,235 $81.3 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $7.21 Million - $9.02 Million	99,932 Added 11.35%	980,487 $86.8 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $8.93 Million - $10.7 Million	-141,785 Reduced 13.87%	880,555 $66.7 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $6.52 Million - $8.34 Million	-99,310 Reduced 8.85%	1,022,340 $74.3 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $10.7 Million - $12.6 Million	-138,920 Reduced 11.02%	1,121,650 $90.4 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $2.96 Million - $3.65 Million	-38,037 Reduced 2.93%	1,260,570 $116 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $118 Million - $131 Million	1,322,169 New	1,322,169 $125 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $3.81 Million - $4.51 Million	42,478 Added 3.38%	1,298,607 $120 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $5.02 Million - $6.72 Million	54,513 Added 4.54%	1,256,129 $119 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $2.28 Million - $2.5 Million	-25,497 Reduced 2.08%	1,201,616 $116 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $85.7 Million - $109 Million	1,227,113	1,227,113 $109 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Abb Vie Inc. Transaction History